Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine Induction Bridge to HCT in Relapsed/Refractory Leukemia
NCT00724009Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Dec 2007
- Primary completion
- Sep 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute leukemia, myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPN), sponsored by University of Chicago. Started Dec 2007; status: completed.
02
Drugs
clofarabine
03
Conditions
acute leukemiamyelodysplastic syndrome (MDS)myeloproliferative neoplasms (MPN)
Beyond the preview
Go deeper on NCT00724009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00724009.